Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C24H30F2O6 |
Molecular Weight | 452.4882 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]3(F)[C@@]2([H])C[C@H](F)C4=CC(=O)C=C[C@]34C
InChI
InChIKey=ISSQQUKLQJHHOR-OSNGSNEUSA-N
InChI=1S/C24H30F2O6/c1-12-7-15-16-9-18(25)17-8-14(28)5-6-21(17,3)23(16,26)19(29)10-22(15,4)24(12,31)20(30)11-32-13(2)27/h5-6,8,12,15-16,18-19,29,31H,7,9-11H2,1-4H3/t12-,15+,16+,18+,19+,21+,22+,23+,24+/m1/s1
Molecular Formula | C24H30F2O6 |
Molecular Weight | 452.4882 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: doi: 10.1016/B978-1-4832-3034-4.50012-0Curator's Comment: description was created based on several sources, including:
DOI: 10.1021/ja01494a054 | https://www.ncbi.nlm.nih.gov/pubmed/4102842
Sources: doi: 10.1016/B978-1-4832-3034-4.50012-0
Curator's Comment: description was created based on several sources, including:
DOI: 10.1021/ja01494a054 | https://www.ncbi.nlm.nih.gov/pubmed/4102842
Flumethasone 21-acetate is an anti-inflammatory corticosteroid. It has 300 times greater anti-inflammatory activity and 677 times greater capacity to promote liver glycogen deposition than hydrocortisone. It has anti-rheumatic potency 31 times higher than cortisol.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Hypersensitivity in mice. II. The effect of chemical compounds on systemic active anaphylaxis and on anaphylaxis-like reactions in normal and B. pertussis-pretreated mice. | 1971 |
|
Versatile system for partition chromatography of corticosteroids and prediction of their elution curves. | 1972 May |
|
Rm values of steroids as an expression of their lipophilic character in structure-activity studies. | 1975 Sep |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4102842
Median effective dose (ED50) 0.1 mg/kg/day. Two injections 48 and 24 h prior to challenge.
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:46:20 GMT 2023
by
admin
on
Fri Dec 15 15:46:20 GMT 2023
|
Record UNII |
HB84ATQ00X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C521
Created by
admin on Fri Dec 15 15:46:20 GMT 2023 , Edited by admin on Fri Dec 15 15:46:20 GMT 2023
|
||
|
CFR |
21 CFR 522.960B
Created by
admin on Fri Dec 15 15:46:20 GMT 2023 , Edited by admin on Fri Dec 15 15:46:20 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2823-42-9
Created by
admin on Fri Dec 15 15:46:20 GMT 2023 , Edited by admin on Fri Dec 15 15:46:20 GMT 2023
|
PRIMARY | |||
|
C77420
Created by
admin on Fri Dec 15 15:46:20 GMT 2023 , Edited by admin on Fri Dec 15 15:46:20 GMT 2023
|
PRIMARY | |||
|
DTXSID50182481
Created by
admin on Fri Dec 15 15:46:20 GMT 2023 , Edited by admin on Fri Dec 15 15:46:20 GMT 2023
|
PRIMARY | |||
|
220-581-6
Created by
admin on Fri Dec 15 15:46:20 GMT 2023 , Edited by admin on Fri Dec 15 15:46:20 GMT 2023
|
PRIMARY | |||
|
DBSALT001651
Created by
admin on Fri Dec 15 15:46:20 GMT 2023 , Edited by admin on Fri Dec 15 15:46:20 GMT 2023
|
PRIMARY | |||
|
11155198
Created by
admin on Fri Dec 15 15:46:20 GMT 2023 , Edited by admin on Fri Dec 15 15:46:20 GMT 2023
|
PRIMARY | |||
|
HB84ATQ00X
Created by
admin on Fri Dec 15 15:46:20 GMT 2023 , Edited by admin on Fri Dec 15 15:46:20 GMT 2023
|
PRIMARY |